Zwitterionic oligonucleotides: A study on binding properties of 2′-O-aminohexyl modifications

Nucleosides, Nucleotides and Nucleic Acids

Volumn 24, Issue 8, 2005, Pages 1167-1185

  Noe, Christian R ^a,b   Winkler, Johannes ^a   Urban, Ernst ^a   Gilbert, Matthias ^b   Haberhauer, Georg ^c   Brunar, Helmut ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b GOETHE UNIVERSITY   (Germany)

^c ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2' O AMINOHEXYLADENOSINE; 2' O AMINOHEXYLURIDINE; 2' O HEPTYLADENOSINE; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; HEXYLAMINE; PHOSPHORAMIDOUS ACID DERIVATIVE; THYMIDINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; DNA CROSS LINKING; DNA STRUCTURE; MOLECULAR INTERACTION; MOLECULAR STABILITY; NUCLEIC ACID SYNTHESIS; SUBSTITUTION REACTION;

AMINES; BASE PAIRING; CIRCULAR DICHROISM; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDES; OLIGODEOXYRIBONUCLEOTIDES;

EID: 31544440989     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1081/NCN-200067400     Document Type: Article

References (42)

1. Dean, N.M.; Bennett, C.F. Antisense oligonucleotide-based therapeutics for cancer. Oncogene 2003, 22(56), 9087-9096.
2. Freier, S.M.; Altmann, K.H. The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically modified DNA:RNA duplexes. Nucleic Acids Res. 1997, 25(22), 4429-4443.
3. Urban, E.; Noe, C.R. Structural modifications of antisense oligonucleotides. Farmaco 2003, 58(3), 243-258.
4. Noe, C.; Brunar, H. Preparation of Modified Oligonucleotides as Active Substances. Wo 9516696, June 22, 1995.
5. Hashimoto, H.; Nelson, M.G.; Switzer, C. Zwitterionic DNA. J. Am. Chem. Soc. 1993, 115(16), 7128-7134.
6. Hashimoto, H.; Nelson, M.G.; Switzer, C. Formation of chimeric duplexes between zwitterionic and natural DNA. J. Org. Chem. 1993, 58(16), 4194-4195.
7. Cotten, M.; Oberhauser, B.; Brunar, H.; Holzner, A.; Issakides, G.; Noe, C.R.; Schaffner, G.; Wagner, E.; Birnstiel, M.L. 2′-O-methyl. 2′-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event. Nucleic Acids Res. 1991, 19(10), 2629-2635.
8. Brunar, H.; Holzner, A.; Issakides, G.; Knollmueller, M.; Noe, C.; Bimstiel, M.; Cotten, M.; Oberhauser, B.; Wagner, E.; Schaffner, G. 2′-O-Alkyl-oligoribonucleotides, Their Synthesis and Use in Antisense Oligonucleotides. Ger. Offen. De 41100851992.
9. Manoharan, M.; Tivel, K.L.; Andrade, L.K.; Cook, P.D. 2′-O- and 3′-O-pyrimidine amino-ether-containing oligodeoxyribonucleotides: synthesis and conjugation chemistry. Tetrahedron Lett. 1995, 36(21), 3647-3650.
10. Haberhauer, G. Ph.D. Thesis; University of Vienna: Austria, 1994.
11. Leonetti, J.P.; Degols, G.; Lebleu, B. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjug. Chem. 1990, 1(2), 149-153.
12. Degols, G.; Leonetti, J.P.; Benkirane, M.; Devaux, C.; Lebleu, B. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res. Dev. 1992, 2(4), 293-301.
13. Clarenc, J.P.; Degols, G.; Leonetti, J.P.; Milhaud, P.; Lebleu, B. Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anti-Cancer Drugs Des. 1993, 8(1), 81-94.
14. Ginobbi, P.; Geiser, T.A.; Ombres, D.; Citro, G. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells. Anticancer Res. 1997, 17(1A), 29-35.
15. Zimmer, A.; Zobel, H.P.; Werner, D.; Noe, C.R.; Kreuter, J. Cationic nanoparticles as enhancers for cellular uptake of antisense oligonucleotides. Proc. Int. Symp. Control. Release Bioact. Mater. 1997, 679-680.
16. Zobel, H.P.; Kreuter, J.; Werner, D.; Noe, C.R.; Kumel, G.; Zimmer, A. Cationic polyhexylcyanoacrylate nanoparticles as carriers for antisense oligonucleotides. Antisense Nucleic Acid Drug Dev. 1997, 7(5), 483-493.
17. Zimmer, A.; Atmaca-Abdel Aziz, S.; Gilbert, M.; Werner, D.; Noe, C.R. Synthesis of cholesterol modified cationic lipids for liposomal drug delivery of antisense oligonucleotides. Eur. J. Pharm. Biopharm. 1999, 47(2), 175-178.
18. Zobel, H.P.; Zimmer, A.; Atmaca-Abdel Aziz, S.; Gilbert, M.; Werner, D.; Noe, C.R.; Kreuter, J.; Stieneker, F. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part 1. Synthesis of monomers, dependence of the physical properties on the polymerization methods. Eur. J. Pharm. Biopharm. 1999, 47(3), 203-213.
19. Junghans, M.; Kreuter, J.; Zimmer, A. Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles. Biochim. Biophys. Acta 2001, 1544(1-2), 177-188.
20. Griffey, R.H.; Monia, B.P.; Cummins, L.L.; Freier, S.; Greig, M.J.; Guinosso, C.J.; Lesnik, E.; Manalili, S.M.; Mohan, V.; Owens, S.; Ross, B.R.; Sasmor, H.; Wancewicz, E.; Weiler, K.; Wheeler, P.D.; Cook, P.D. 2′-O-aminopropyl ribonucleotides: a zwitterionic modification that enhances the exonuclease resistance and biological activity of antisense oligonucleotides. J. Med. Chem. 1996, 39(26), 5100-5109.
21. Manoharan, M.; Prakash, T.P.; Barber-Peoc'h, I.; Bhat, B.; Vasquez, G.; Ross, B.S.; Cook, P.D. N-(2-cyanoethoxycarbonyloxy)succinimide: a new reagent for protection of amino groups in oligonucleotides. J. Org. Chem. 1999, 64(17), 6468-6472.
22. Manoharan, M. Antisense Drug Technology; Crooke, S.T., Ed.; Marcel Dekker: New York, 2001; 391-470.
23. Teplova, M.; Wallace, S.T.; Tereshko, V.; Minasov, G.; Symons, A.M.; Cook, P.D.; Manoharan, M.; Egli, M. Structural origins of the exonuclease resistance of a zwitterionic RNA. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(25), 14240-14245.
24. Potier, P.; Abdennaji, A.; Behr, J.P. Synthesis and hybridization properties of oligonucleotides containing polyamines at the C-2 position of purines: a pre-synthetic approach for the incorporation of spermine into oligodeoxynucleotides containing 2-(4,9,13-triazatridecyl)-2′- deoxyguanosine. Chemistry 2000, 6(22), 4188-4194.
25. Potier, P.F.; Behr, J.P. Recognition of DNA by strand invasion with oligonucleotide-spermine conjugates. Nucleosides Nucleotides Nucleic Acids 2001, 20(4-7), 809-813.
26. Manoharan, M.; Inamati, G.; Tivel, K.L.; Wheeler, P.; Stecker, K.; Cook, P.D. 2′- and 3′-biotin conjugated nucleoside building blocks: synthesis of biotinylated oligonucleotides. Nucleosides Nucleotides 1997, 16(7-9), 1411-1413.
27. Whittemore, N.A.; Mullenix, A.N.; Inamati, G.B.; Manoharan, M.; Cook, P.D.; Tuinman, A.A.; Baker, D.C.; Chambers, J.Q. Synthesis and electrochemistry of anthraquinone-oligodeoxynucleotide conjugates. Bioconjug. Chem. 1999, 10(2), 261-270.
28. Manoharan, M.; Tivel, K.L.; Zhao, M.; Nafisi, K.; Netzel, T.L. Base-sequence dependence of emission lifetimes for D141018-30-6NA oligomers and duplexes covalently labeled with pyrene: relative electron-transfer quenching efficiencies of A, G, C, and T nucleosides toward pyrene. J. Phys. Chem. 1995, 99(48), 17461-17472.
29. Lamond, A.I.; Sproat, B.S. Antisense oligonucleotides made of 2′-O-alkylRNA: their properties and applications in RNA biochemistry. FEBS Lett. 1993, 325(1-2), 123-127.
30. Manoharan, M. 2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. Biochim. Biophys. Acta 1999, 1489(1), 117-130.
31. Monia, B.P.; Lesnik, E.A.; Gonzalez, C.; Lima, W.F.; McGee, D.; Guinosso, C.J.; Kawasaki, A.M.; Cook, P.D.; Freier, S.M. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 1993, 268(19), 14514-14522.
32. Wagner, E.; Oberhauser, B.; Holzner, A.; Brunar, H.; Issakides, G.; Schaffner, G.; Cotten, M.; Knollmueller, M.; Noe, C.R. A simple procedure for the preparation of protected 2′-O-methyl- or 2′-O- ethylribonucleoside 3′-O-phosphoramidites. Nucleic Acids Res. 1991, 19(21), 5965-5971.
33. Corey, E.J.; Gras, J.L.; Ulrich, P. A new general method for protection of the hydroxyl function. Tetrahedron Lett. 1976, 17(11), 809-812.
34. Wagner, D.; Verheyden, J.P.H.; Moffatt, J.G. Preparation and synthetic utility of some organo tin derivatives of nucleosides. J. Org. Chem. 1974, 39(1), 24-30.
35. Hasan, S.K.; Wasson, F.I.; Wolfe, S. Five-membered rings. I. Reaction of 2-methyl-2-oxazoline with phthalimidoacetyl chloride. Can. J. Chem. 1967, 45(17), 2000-2002.
36. Sinha, N.D.; Biernat, J.; Koester, H. b-Cyanoethyl N,N-dialkylamino/N- morpholinomonochlorophosphoamidites, new phosphitylating agents facilitating ease of deprotection and work-up of synthesized oligonucleotides. Tetrahedron Lett. 1983, 24(52), 5843-5846.
37. Cantor, C.R.; Schimmel, P.R. Biophysical Chemistry of Macromolecules, Pt. 3: The Behaviour of Biological Macromolecules; W. H. Freeman: San Francisco, 1980.
38. Wang, A.H.; Fujii, S.; van Boom, J.H.; van der Marel, G.A.; van Boeckel, S.A.; Rich, A. Molecular structure of r(GCG)d(TATACGC): a DNA-RNA hybrid helix joined to double helical DNA. Nature 1982, 299(5884), 601-604.
39. Zimmerman, S.B.; Pheiffer, B.H. A RNA:DNA hybrid that can adopt two conformations: an x-ray diffraction study of poly(rA):poly(dT) in concentrated solution or in fibers. Proc. Natl. Acad. Sci. U. S. A. 1981, 78(1), 78-82.
40. Peck, L.J.; Wang, J.C. Sequence dependence of the helical repeat of DNA in solution. Nature 1981, 292(5821), 375-378.
41. Rhodes, D.; Klug, A. Sequence-dependent helical periodicity of DNA. Nature 1981, 292(5821), 378-380.
42. Werner, D.; Brunar, H.; Noe, C.R. Investigations on the influence of 2′-O-alkyl modifications on the base pairing properties of oligonucleotides. Pharm. Acta Helv. 1998, 73(1), 3-10.